Robert CPA - Acasti Pharma Principal Officer
| ACSTDelisted Stock | USD 3.37 0.01 0.30% |
Executive
Robert CPA is Principal Officer of Acasti Pharma
| Age | 52 |
| Phone | 818-839-4378 |
| Web | https://www.acastipharma.com |
Acasti Pharma Management Efficiency
The company has return on total asset (ROA) of (0.1162) % which means that it has lost $0.1162 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1856) %, meaning that it created substantial loss on money invested by shareholders. Acasti Pharma's management efficiency ratios could be used to measure how well Acasti Pharma manages its routine affairs as well as how well it operates its assets and liabilities.Acasti Pharma currently holds 11.56 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Acasti Pharma has a current ratio of 10.91, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Acasti Pharma's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Sina Bavari | Tonix Pharmaceuticals Holding | N/A | |
| BethAnne Lang | Akari Therapeutics PLC | N/A | |
| Dr MBA | Tonix Pharmaceuticals Holding | 66 | |
| Uttam Patil | ABVC Biopharma | 38 | |
| MPH MD | Tonix Pharmaceuticals Holding | N/A | |
| Carol MBA | Jaguar Animal Health | 60 | |
| Darryl Rideout | Tonix Pharmaceuticals Holding | N/A | |
| Karen Brunke | Jaguar Animal Health | 72 | |
| CMI MD | Ocugen Inc | N/A | |
| Michael MBA | Ocugen Inc | N/A | |
| MD III | Akari Therapeutics PLC | 71 | |
| Anthony Price | Bio Path Holdings | N/A | |
| Dolly Tyan | Aditxt Inc | N/A | |
| John Niles | GeoVax Labs | N/A | |
| Peter Hodge | Jaguar Animal Health | N/A | |
| David JD | Pulmatrix | 66 | |
| Dr D | Aditxt Inc | N/A | |
| John JD | Ocugen Inc | N/A | |
| CMA CPA | Ocugen Inc | N/A | |
| Gregory MD | Tonix Pharmaceuticals Holding | 58 | |
| Marc JD | Ibio Inc | N/A | |
Management Performance
| Return On Equity | -0.19 | |||
| Return On Asset | -0.12 |
Acasti Pharma Leadership Team
Elected by the shareholders, the Acasti Pharma's board of directors comprises two types of representatives: Acasti Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Acasti. The board's role is to monitor Acasti Pharma's management team and ensure that shareholders' interests are well served. Acasti Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Acasti Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| George Kottayil, Chief US | ||
| Robert CPA, Principal Officer | ||
| Prashant Kohli, Chief Officer | ||
| Amresh Kumar, VP Management | ||
| Janelle DAlvise, President CEO | ||
| Yves Lachance, VP Compliance | ||
| Carrie DAndrea, VP Operations | ||
| Pierre MD, COO CoFounder | ||
| Christine Pelletier, Director HR |
Acasti Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Acasti Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.19 | |||
| Return On Asset | -0.12 | |||
| Current Valuation | 11.17 M | |||
| Shares Outstanding | 10.14 M | |||
| Shares Owned By Insiders | 38.39 % | |||
| Shares Owned By Institutions | 21.22 % | |||
| Number Of Shares Shorted | 154.19 K | |||
| Price To Earning | 15.34 X | |||
| Price To Book | 0.58 X | |||
| Price To Sales | 208.39 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Acasti Stock
If you are still planning to invest in Acasti Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acasti Pharma's history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |